Vericel Corporation ( VCEL) - Stock Earnings
VCEL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
VCEL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 23.2 million USD | 92.9 million USD |
| 2026Q1 | -6.3 million USD | 68.4 million USD |
| 2026Q2 | 2.2 million USD | 77.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
VCEL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.2 million USD | 197.5 million USD |
| 2024 | 10.4 million USD | 237.2 million USD |
| 2025 | 16.5 million USD | 276.3 million USD |
| 2026 Est. | — | — |
VCEL
Price: $41.02
Earnings Per Share: 0.48 USD
P/E Ratio: 96.54
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 122353
Ebitda: -4.7 millionMarket Capitalization: 2.1 billion